Context Although magnetic resonance imaging (MRI) is broadly implemented into active
surveillance (AS) protocols, data on the reliability of serial MRI in order to help guide follow …

Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Active surveillance (AS) is the recommended treatment option for low-risk and favourable
intermediate-risk prostate cancer management, preserving oncological and functional …

Context The role of multiparametric magnetic resonance imaging (mp-MRI) during active
surveillance (AS) of prostate cancer needs evaluation. It remains unclear whether mp-MRI …

Simple Summary Recently, biomarkers have become a supplemental tool to aid in the
diagnosis and evaluation of prostate cancer. Numerous biomarkers are being developed …

Active surveillance for low-to-intermediate risk prostate cancer is a conservative
management approach that aims to avoid or delay active treatment until there is evidence of …

Objectives To investigate whether serial prostate magnetic resonance imaging (MRI) may
guide the utility of repeat targeted (TBx) and systematic biopsy (SBx) when monitoring men …

Background The inclusion criterion for active surveillance (AS) is low-or intermediate-risk
prostate cancer. The predictive value of the presence of a suspicious lesion at magnetic …

Abstract Background Although the Decipher genomic classifier has been validated as a
prognostic tool for several prostate cancer endpoints, little is known about its role in …

Purpose: This study aimed to assess the medium-term oncologic outcomes of an active
surveillance protocol, replacing confirmatory biopsy with serial multiparametric magnetic …